Kim J and Alger BE |
Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus. |
2004 |
Nat. Neurosci. |
pmid:15184902
|
Witting A et al. |
Endocannabinoids accumulate in spinal cord of SOD1 G93A transgenic mice. |
2004 |
J. Neurochem. |
pmid:15189359
|
Stanke-Labesque F et al. |
2-Arachidonoyl glycerol induces contraction of isolated rat aorta: role of cyclooxygenase-derived products. |
2004 |
Cardiovasc. Res. |
pmid:15194472
|
Oka S et al. |
2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces the migration of EoL-1 human eosinophilic leukemia cells and human peripheral blood eosinophils. |
2004 |
J. Leukoc. Biol. |
pmid:15316028
|
Nithipatikom K et al. |
2-arachidonoylglycerol: a novel inhibitor of androgen-independent prostate cancer cell invasion. |
2004 |
Cancer Res. |
pmid:15604240
|
González S et al. |
Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence. |
2004 |
Drug Alcohol Depend |
pmid:15099659
|
Valenti M et al. |
Differential diurnal variations of anandamide and 2-arachidonoyl-glycerol levels in rat brain. |
2004 |
Cell. Mol. Life Sci. |
pmid:15095014
|
Kishimoto S et al. |
2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces accelerated production of chemokines in HL-60 cells. |
2004 |
J. Biochem. |
pmid:15115777
|
Malorni W et al. |
Morphological evidence that 2-arachidonoylglycerol is a true agonist of human platelets. |
2004 |
Thromb. Haemost. |
pmid:15543349
|
Melis M et al. |
Prefrontal cortex stimulation induces 2-arachidonoyl-glycerol-mediated suppression of excitation in dopamine neurons. |
2004 |
J. Neurosci. |
pmid:15564588
|
Sugiura T et al. |
New perspectives in the studies on endocannabinoid and cannabis: 2-arachidonoylglycerol as a possible novel mediator of inflammation. |
2004 |
J. Pharmacol. Sci. |
pmid:15599096
|
Saario SM et al. |
Monoglyceride lipase-like enzymatic activity is responsible for hydrolysis of 2-arachidonoylglycerol in rat cerebellar membranes. |
2004 |
Biochem. Pharmacol. |
pmid:15013854
|
Alberich Jordà M et al. |
The peripheral cannabinoid receptor Cb2, frequently expressed on AML blasts, either induces a neutrophilic differentiation block or confers abnormal migration properties in a ligand-dependent manner. |
2004 |
Blood |
pmid:15039279
|
Witting A et al. |
P2X7 receptors control 2-arachidonoylglycerol production by microglial cells. |
2004 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:14976257
|
Carrier EJ et al. |
Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism. |
2004 |
Mol. Pharmacol. |
pmid:15044630
|
Golech SA et al. |
Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors. |
2004 |
Brain Res. Mol. Brain Res. |
pmid:15548432
|
Mukherjee S et al. |
Species comparison and pharmacological characterization of rat and human CB2 cannabinoid receptors. |
2004 |
Eur. J. Pharmacol. |
pmid:15556131
|
Guo J and Ikeda SR |
Endocannabinoids modulate N-type calcium channels and G-protein-coupled inwardly rectifying potassium channels via CB1 cannabinoid receptors heterologously expressed in mammalian neurons. |
2004 |
Mol. Pharmacol. |
pmid:14978245
|
Piomelli D |
The endogenous cannabinoid system and the treatment of marijuana dependence. |
2004 |
Neuropharmacology |
pmid:15464150
|
Motobe T et al. |
Endogenous cannabinoids are candidates for lipid mediators of bone cement implantation syndrome. |
2004 |
Shock |
pmid:14676677
|